Invitrogen has made its first foray into the next-generation sequencing field with an OEM agreement this week to supply Solexa with most of the reagents that its as-yet unreleased Genome Analysis System will use for sequencing, gene expression, and small RNA analysis applications.

The pact marks Invitrogen's first play in DNA sequencing in general and in the next-generation sequencing field in particular, but with a growing number of startups in the market the firm hopes to sign on additional partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.